Group 1: Company Updates - Several companies, including 美之选 (MEDG), Ga Sai Tong (GST), 青民数科 (QMSK), 星妍 (AGIE), and 中毅资本, have updated their prospectuses to advance their respective U.S. IPO processes [1][3][5][7][9] - 美之选 plans to issue 3.33 million shares at a price range of $4 to $5 per share, aiming to raise between $13.33 million and $16.67 million [1][3] - Ga Sai Tong intends to issue 1.3 million shares at a price range of $5 to $7 per share, with a fundraising target of $6.5 million to $9.1 million [1][5] - 青民数科 plans to issue 6.25 million shares at a price range of $4 to $6 per share, targeting $25 million to $37.5 million in fundraising [1][7] - 星妍 aims to issue 1.5 million shares at a price range of $4 to $6 per share, with a fundraising goal of $6 million to $9 million [1][8] Group 2: Financial Performance - 美之选 reported revenue of $3.25 million and a net profit of $0.98 million for the six months ending December 31, 2024 [3] - Ga Sai Tong generated revenue of $1.36 million and a net profit of $0.25 million for the first half of 2025 [5] - 青民数科 reported revenue of $52.86 million and a net profit of $2.25 million for the twelve months ending March 31, 2025 [7] - 星妍 achieved revenue of $4.51 million and a net profit of $0.49 million for the six months ending June 30, 2025 [8] - 中毅资本 reported revenue of $0.654 million but incurred a net loss of $0.189 million for the twelve months ending March 31, 2025 [9] Group 3: Market Overview - The global medical aesthetic services market was valued at $15.304 billion in 2023 and is projected to grow at a CAGR of 11% from 2023 to 2028, with non-surgical procedures expected to outpace surgical ones [25] - The beauty and personal care market in Hong Kong is projected to grow at a CAGR of 1.9% from 2024 to 2028, while the skincare segment is expected to grow at a CAGR of 1.81% during the same period [25]
美之选等5家中企更新招股书 附上市路演PPT